U.S., Jan. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07317102) titled 'Omnipod-5 A French Prospective Multicentric Study in Real World (Optimal-B)' on Dec. 18, 2025.
Brief Summary: The purpose of this postmarket clinical investigation is to evaluate the levels of glycemic control, quality of life, and satisfaction, as well as the patient experience, and acute diabetes complication rates provided by the Omnipod 5 Automated Insulin Delivery System (referred to as the Omnipod 5 System) in a real-world setting.
Study Start Date: Feb., 2026
Study Type: OBSERVATIONAL
Condition:
Diabetes
Type 1 Diabetes
Diabetes Mellitus
Intervention:
DEVICE: Omnipod 5
The Omnipod 5 Automated Insulin Delivery System (Om...